Business Description

Description
Biostax Corp is a biotechnology company utilizing the Biostax Development Engine, is a developer and marketer of pharmaceutical, biotechnology and MedTech products that have a well-defined path to market. The Company is focused on driving the development and commercialization of proprietary mechanisms to prevent, intercept and improve these diseases at affordable cost. It is a therapeutic and health tech agnostic, constantly seeking assets with low acquisition costs and high growth opportunities having significant clinical and commercial potential.

Financial Strength

Name Current Vs Industry Vs History
Equity-to-Asset -4.75
Debt-to-Equity -0.32
Debt-to-EBITDA -0.79
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 38.51
9-Day RSI 38.92
14-Day RSI 41.18
6-1 Month Momentum % -73.33
12-1 Month Momentum % -88.89

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -466.2
Shareholder Yield % 19.68

Profitability Rank

Name Current Vs Industry Vs History
ROA % -230.61
ROIC % -97.49
Years of Profitability over Past 10-Year 2

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -4.22
EV-to-EBITDA -4.33
EV-to-FCF -41.45
Earnings Yield (Greenblatt) % -23.7
FCF Yield % -3.04

Financials (Next Earnings Date:2024-05-10 Est.)

BTAX's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:BTAX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Biostax Corp Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.023
Beta 0.1
Volatility % 151.16
14-Day RSI 41.18
14-Day ATR ($) 0.001403
20-Day SMA ($) 0.060982
12-1 Month Momentum % -88.89
52-Week Range ($) 0.055 - 0.9
Shares Outstanding (Mil) 83.66

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Biostax Corp Filings

Filing Date Document Date Form
No Filing Data

Biostax Corp Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Biostax Corp Frequently Asked Questions

What is Biostax Corp(BTAX)'s stock price today?
The current price of BTAX is $0.06. The 52 week high of BTAX is $0.90 and 52 week low is $0.06.
When is next earnings date of Biostax Corp(BTAX)?
The next earnings date of Biostax Corp(BTAX) is 2024-05-10 Est..
Does Biostax Corp(BTAX) pay dividends? If so, how much?
Biostax Corp(BTAX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1